tDCS to Decrease Opioid Relapse (UH3)

Abroad (travel likely)Recruiting

Conditions

Opioid Use Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Butler Hospital, Providence, Rhode Island, United States
Contact: Study coordinator (Ana M Abrantes, Ph.D.) · ana_abrantes@brown.edu · 4014556440
Contact: Principal Investigator (Ana M. Abrantes, Ph.D.)
Contact: Principal Investigator (Michael Stein, M.D.)

Study leads

Abrantes Abrantes, Ph.D.
Principal Investigator
Butler Hospital
Michael Stein, M.D.
Principal Investigator
Boston University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Low-dose Buprenorphine Initiation for Opioid Use Disorder

Opioid Use Disorder

Abroad (travel likely)RecruitingPHASE4

The Bronx, United States

A Study of Brenipatide in Participants With Opioid Use Disorder

Opioid Use Disorder

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Little Rock, United States

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use

Opioid Use Disorder

Abroad (travel likely)RecruitingPHASE2

Philadelphia, United States

Telehealth vs In-Person Evaluation of Addiction Treatment After Visiting the Emergency Department

Opioid Use Disorder

Abroad (travel likely)Recruiting

El Centro, United States · Sacramento, United States